Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical Trial

2021-07-07T11:41:13+00:00July 7, 2021|Investor Information, Psychedelic News, Press Releases|

Psyence has signed a partnership agreement with Clerkenwell Health, a leading psychedelic Contract Research Organisation (CRO) based in the United Kingdom to develop market leading clinical trials in the field of palliative care. Clerkenwell will be responsible for jointly designing and delivering the UK clinical trial. Palliative care is the treatment and alleviation of suffering for those facing a serious acute or persistent medical issue, whether the prognosis is deemed terminal or chronic and ongoing.